Harkins, Merski applaud $1.7M investment in Erie’s life sciences industry
Will fund First Ascent Biomedical space at Gannon University
Rep. Robert Merski March 26, 2025 | 1:42 PM
ERIE, March 26 – State Reps. Pat Harkins and Bob Merski, both D-Erie, announced their strong support for Gov. Josh Shapiro’s recent announcement of a significant investment of more than $1.7 million to grow the life sciences industry in Erie. They said the funding will enable the development of a new First Ascent Biomedical laboratory space at Gannon University in Erie, creating 38 new jobs and advancing cancer treatment innovation.
The project involves a $1.13 million investment by First Ascent Biomedical to lease the new, 5,000-square-foot laboratory and office space from Gannon University. The facility will house a Clinical Laboratory Improvement Amendments-certified laboratory equipped with state-of-the-art robotic technology capable of processing tissue samples annually for thousands of cancer patients.
The funding package includes $1.5 million from the state Pennsylvania Department of Community and Economic Development to support construction costs at Gannon University, with an additional $220,000 allocated for First Ascent’s growth. Contributions from Erie County, as well as non-profit and the private sector further solidify the collaboration making this laboratory possible.
“This partnership between Gannon University and First Ascent Biomedical is transformative for our region,” Harkins said. “It’s not only about creating new jobs -- it’s about positioning Erie as a leader in life sciences innovation while directly improving the lives of patients battling cancer.”
Merski added, “This is what happens when we invest in our community’s talent and potential. By bringing together state funding, academic expertise and private enterprise, we’re creating a future where Erie leads in cutting-edge health care and provides meaningful opportunities for our residents.”
First Ascent Biomedical, founded in 2018, specializes in companion diagnostic testing supporting precision oncology. Their advanced methods use AI-enhanced Functional Precision Medicine to revolutionize cancer treatment. With top-tier research and collaboration at its core, the company’s work is changing how cancer is treated worldwide.